Neuroone Medical Technologies (NMTC) Net Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 42.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -87.88% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -48.90% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 129.29% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -65.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 33.47% |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | 10.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.74% |
| Dec 31, 2025 | 4.85% |
| Sep 30, 2025 | 10.04% |
| Jun 30, 2025 | 65.06% |
| Mar 31, 2025 | 27.16% |
| Dec 31, 2024 | -26.72% |
| Sep 30, 2024 | 57.54% |
| Jun 30, 2024 | 29.08% |
| Mar 31, 2024 | -27.23% |
| Dec 31, 2023 | -41.85% |
| Sep 30, 2023 | 119.25% |
| Jun 30, 2023 | -29.44% |
| Mar 31, 2023 | 6.35% |
| Dec 31, 2022 | -58.19% |
| Sep 30, 2022 | -26.96% |
| Jun 30, 2022 | -36.48% |
| Jun 30, 2021 | -263.81% |
| Mar 31, 2021 | 259.86% |
| Dec 31, 2020 | 317.93% |
| Sep 30, 2020 | 37.58% |
| Jun 30, 2020 | 267.02% |
| Mar 31, 2020 | -230.90% |
| Dec 31, 2019 | 50.60% |
| Jun 30, 2018 | -1,580.29% |
| Mar 31, 2018 | -2,002.78% |
| Jun 30, 2017 | -612.90% |
| Mar 31, 2017 | -1,027.14% |
| Dec 31, 2016 | 1,746.31% |
| Dec 31, 2015 | 17.64% |
| Jun 30, 2015 | 26.08% |
| Mar 31, 2015 | 87.81% |
| Jun 30, 2014 | 29.11% |
| Mar 31, 2014 | 84.46% |
| Dec 31, 2013 | -27.18% |
| Sep 30, 2013 | -28.86% |